Mr Mrs Miss Ms Dr Other

Dr
Alex
Colman

Patent Director

Manchester Office

Engineering

Telephone. +44(0) 161 247 4900
Email. [email protected]

Experience

Alex is pragmatic and straight-talking. Whether working with in-house counsel at large corporates or first-time patent applicants, he garners praise for guiding clients through the complexities of patent issues to achieve solutions most useful to their businesses. He has expertise in delivering great value advice, having made a speciality of helping clients with tight margins and those in the early stages of commercialising their ideas.

His colleagues describe him as a safe pair of hands, which is why Alex handles matters for some of HGF’s largest clients, and helps to develop its commercial relationships. Clients benefit from his creative ability to revitalise the fortunes of the most struggling patent applications before both the UK Intellectual Property Office and the European Patent Office.

As an engineer-turned-lawyer, Alex's practice is focused primarily on building technologies and construction products, including green technologies embodying energy reduction and decarbonisation, and producing renewable energy, as well as medical devices, particularly injectables and wound care, automotive technologies and textiles.

Alex came to HGF from Newcastle University, where he gained a first-class Master’s degree in civil and structural engineering, and a PhD in structural engineering.

Qualifications

Patent Attorney

Chartered (UK)
Europe


MENG

Civil and Structural Engineering

PHD

Structural Engineering

Publications

Profiting from Innovation Within Product Platforms

View publication online

Coronavirus update: Oral proceedings before Opposition Divisions and Boards of Appeal

View publication online

Conferences: 2022

June 24th 2022

pro-manchester Trailblazing Tech Conference 2022

Speaker

Event details

Related News

Agritech Thymes: Exploring the Agritech IP landscape – past trends and future insights

The agrifood patent landscape analysis recently reported by WIPO provides interesting insights into key areas of innovation and the IP strategies being adopted. The agrifood industry, encompassing both agritech and …

Read article
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Patent applications and grants in Europe

HGF is pleased to invite you to our upcoming German-language seminar on “Patent applications and grants in Europe” in Salzburg and Dresden. The seminar provides participants with a comprehensive overview …

Event details
Event - 10th October 2024

Webinar: Patents and business activities in harmony

In today’s highly competitive world, patents are not only a legal tool but also a strategic instrument to strengthen your market position and maximise your business success. But how do …

Event details
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Basics of trade mark protection - National and European perspectives

HGF is pleased to invite you to our upcoming German speaking seminar on “Fundamentals of trade mark protection: National and European Perspectives” in Salzburg and Dresden. The seminar will cover …

Event details

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

How to Use IP Strategy to Tip the Odds in Your Favour

Porter’s Five Forces model [1] is just one example of a convenient model for exploring and understanding the forces at play in a competitive marketplace. Michael Porter’s Five Forces model …

Read article

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.